In a wide-ranging interview, Mitchell discussed the Purchaser Business Group Health’s health data demonstration project, ...
Breast cancer screening based on individual risk rather than annual screening is safe, effective and preferred by patients, ...
It was announced today that Jefferson Health, Penn Medicine and Temple Health have been selected as the 2026 Clinical Care ...
An update from the phase 2 LEGEND trial shows that the investigational nonviral gene therapy detalimogene voraplasmid has achieved a 62% complete response rate at six months in patients with high-risk ...
Shekhar Khera, senior vice president, product management at RxBenefits, discusses the role of artificial intelligence in ...
BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated ...
Although three-fourths (76%) of breast cancer patients are exposed to cancer misinformation, perpetuating fear in 38%, it did ...
The Pharmaceutical Care Management Association (PCMA) has named David Marin, J.D., as its new president and CEO, effective ...
In 2026, AI will continue threading itself into behavioral health, and the bar will rise sharply for what counts as ...
Lenacapavir, a long-acting injectable PrEP, requires two injections annually, marking a significant advancement in HIV ...
Medicaid expansion under the ACA improved long-term survival for younger adults with operable lung cancer, despite no earlier ...
At the 2025 AMCP annual meeting in Houston, John M. O'Brien, Pharm.D., M.P.H., president and CEO of the National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback